Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record shows administrative updates, including a new revision (v3.6.4) and recent update dates, reflecting maintenance of the ClinicalTrials.gov page rather than substantive changes to the study design or results.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2 revision.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows a new revision identifier v3.6.2 and removes the previous v3.6.0 from the revision history. This reflects an update to the page's revision record.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a recruitment notice showing no enrollment. The page also introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows a revision update (v3.6.0) with a formatting tweak to the Intervention/Treatment header.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page version without changing the study content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision has been updated from v3.5.3 to v3.5.4, indicating a minor administrative update to the page.SummaryDifference0.1%

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.